October 18, 2022
How to Effectively Treat Difficult Patients, Part 1
MLMIC shares guidance for interacting with patients who are hostile, drug seeking or noncompliant.
Tag: prescriptions
October 18, 2022
MLMIC shares guidance for interacting with patients who are hostile, drug seeking or noncompliant.
September 28, 2022
Responsibly prescribing medications, identifying patients with opioid use disorders, initiating conversations and developing treatment plans may help physicians handle drug-seeking patients while mitigating risk.
January 10, 2022
As cannabis use becomes more widespread, conversations with patients about its use may help to prevent poor medical outcomes.
June 23, 2021
New research indicates there are not significant differences in clinical outcomes or overall experiences between post-surgical patients who receive narcotics and those treated with over-the-counter NSAIDs.
June 14, 2021
The Biden-Harris Administration recently released its Statement of Drug Policy Priorities to continue the effort to end the opioid epidemic. The list works in tandem with the American Dental Association’s similar goals to curb opioid use. Knowledge about opioid prescription misuse is crucial for dentists, who prescribe 1 in 10 opioid prescriptions in the United States.
May 21, 2021
A troubling percentage of long-COVID patients are using opioids to address the scope of symptoms that can cripple one’s health for months after a diagnosis.
March 10, 2021
Experts say patient-centric opioid intervention before discharge from the hospital can cut overall opioid intake, while still ensuring a patient is satisfied and their pain is properly managed.
January 4, 2021
The newest issue of The Scope: Medical Edition, MLMIC’s risk management publication, is now available online and offers the latest health, legal, risk management and insurance information.
November 20, 2020
MLMIC encourages policyholders to review these important Risk Management Checklists on opioid management, including guidance on managing patients with chronic pain and managing drug seeking patients.
September 30, 2020
The FDA cautions that a number of websites are illegally selling unauthorized opioids that may be counterfeit, contaminated, expired or otherwise unsafe.